MICHAEL M GOLDBERG

CIK 905011 · President & CEO · last filed 2017-05-16

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.37M

Companies

4

Total Filings

27

Lifetime Open-Market Net

$107.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted President & CEO 5,921,023 $0.00 $592 $107.7K 12 2017-05-16
Echo Therapeutics, Inc. (ECTE) Delisted Director 14,500 $0 4 2016-03-22
Savara Inc (ANX) Delisted Director $0 4 2010-07-01
EMIS Director 135,123 $10.15 $1.37M $0 2 2007-08-31

Recent Filings · Page 3 of 3

27 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2010-07-01 Savara Inc (ANX) Delisted Grant (A) $0 EDGAR
2010-02-03 Savara Inc (ANX) Delisted Grant (A) $0 EDGAR
2009-09-18 Other (J) $0
2008-07-02 Savara Inc (ANX) Delisted Grant (A) $0 EDGAR
2007-08-31 EMIS Buy (P) +99,246 $0 EDGAR
2007-05-25 Savara Inc (ANX) Delisted Grant (A) $0 EDGAR
2007-04-30 EMIS Grant (A) +2,660 $0 EDGAR
Showing 2127 of 27
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.